Baccarani, Michele http://orcid.org/0000-0003-1999-1687
Bonifazi, Francesca http://orcid.org/0000-0003-1544-9911
Soverini, Simona http://orcid.org/0000-0002-4508-0353
Castagnetti, Fausto
Gugliotta, Gabriele
Saber, Wael
Estrada-Merly, Noel
Rosti, Gianantonio
Gale, Robert Peter http://orcid.org/0000-0002-9156-1676
Article History
Received: 14 January 2022
Revised: 25 January 2022
Accepted: 2 February 2022
First Online: 25 March 2022
Competing interests
: FB received speaker fees from NEOVII Biotech, JAZZ pharmaceuticals, Novartis, Celgene, MSD, Pfizer and Amgen. SS received speaker fees from Incyte Biosciences and Bio-Rad and is a consultant to Incyte Biosciences and Cepheid. FC received speaker fees and is a consultant to Novartis, Pfizer, Bristol-Myers Squibb and Incyte Biosciences. GG received speaker fees from Novartis and Incyte Biosciences. WS reports no conflict of interests. NEM reports no conflict of interests. GR received speaker fees from and is a consultant to Novartis, Pfizer, Bristol-Myers Squibb and Incyte Biosciences. RPG is a consultant to BeiGene Ltd., Fusion Pharma LLC, LaJolla NanoMedical Inc., Mingsight Parmaceuticals Inc. CStone Pharmaceuticals, NexImmune Inc. and Prolacta Bioscience; advisor to Antengene Biotech LLC, Medical Director, FFF Enterprises Inc.; partner, AZAC Inc.; Board of Directors, Russian Foundation for Cancer Research Support; and Scientific Advisory Board: StemRad Ltd.